Leatt Corporation (LEAT)

Verve Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 1, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	61	44	57	111	183	40
Market Cap Growth	-24.34%	-23.71%	-48.49%	-39.41%	358.42%	218.97%
Enterprise Value	49	32	47	107	182	38
Last Close Price	9.76	7.00	9.55	19.00	32.50	7.40
PE Ratio	-	-	71.00	11.12	14.53	9.01
PS Ratio	1.24	0.99	1.21	1.45	2.52	1.03
PB Ratio	1.53	1.14	1.42	2.79	6.39	2.59
P/TBV Ratio	1.53	1.14	1.42	2.79	6.39	2.59
P/FCF Ratio	-	27.83	12.24	56.99	111.21	45.83
P/OCF Ratio	82.80	15.58	8.57	35.86	65.68	16.98
EV/Sales Ratio	1.00	0.72	1.00	1.41	2.51	0.97
EV/EBITDA Ratio	40.01	-	18.26	7.61	10.30	5.64
EV/EBIT Ratio	-	-	33.37	8.25	10.94	6.44
EV/FCF Ratio	-76.09	20.30	10.16	55.25	110.63	43.20
Debt / Equity Ratio	0.03	0.03	0.05	0.06	0.09	0.06
Debt / EBITDA Ratio	0.81	-	0.67	0.16	0.15	0.14
Debt / FCF Ratio	-	0.84	0.46	1.22	1.61	1.11
Asset Turnover	1.09	0.94	0.95	1.51	1.92	1.74
Inventory Turnover	1.67	1.37	1.27	2.06	2.67	2.32
Quick Ratio	3.46	2.44	2.81	1.78	0.95	0.97
Current Ratio	7.26	5.20	6.27	4.25	2.38	2.16
Return on Equity (ROE)	-0.68%	-5.61%	2.01%	29.16%	57.17%	33.91%
Return on Assets (ROA)	-1.06%	-3.96%	1.78%	16.10%	27.54%	16.42%
Return on Capital (ROIC)	-1.17%	-4.54%	2.10%	22.19%	43.64%	25.74%
Return on Capital Employed (ROCE)	-	-	3.50%	32.00%	54.60%	37.20%
Earnings Yield	-0.44%	-5.07%	1.41%	9.00%	6.88%	11.10%
FCF Yield	-1.06%	3.59%	8.17%	1.75%	0.90%	2.18%
Buyback Yield / Dilution	-2.69%	1.15%	-2.46%	-1.13%	-1.29%	-8.02%

Updated Oct 29, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.